T1	PROC 46 133	Estudio multicéntrico, aleatorizado, con doble enmascaramiento y controlado con placebo
T2	DISO 1124 1152	absceso abdominal o perianal
T3	PROC 187 198	endoscópica
#1	AnnotatorNotes T3	C0014245; Endoscopy (procedure); Diagnostic Procedure
T4	DISO 216 235	enfermedad de Crohn
#2	AnnotatorNotes T4	C0010346; Crohn Disease; Disease or Syndrome
T5	PROC 318 329	tratamiento
#3	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 330 338	anti-TNF
#4	AnnotatorNotes T6	C1562242; Anti-tumor necrosis factor alpha drug (product); Pharmacologic Substance · Immunologic Factor (?)
T7	PROC 359 370	tratamiento
#5	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	DISO 394 413	Enfermedad de Crohn
#6	AnnotatorNotes T8	C0010346; Crohn Disease; Disease or Syndrome
T9	PROC 511 522	Diagnóstico
#7	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	DISO 526 545	enfermedad de Crohn
#8	AnnotatorNotes T10	C0010346; Crohn Disease; Disease or Syndrome
T11	PROC 686 697	tratamiento
#9	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 712 720	anti-TNF
#10	AnnotatorNotes T12	C1562242; Anti-tumor necrosis factor alpha drug (product); Immunologic Factor · Pharmacologic Substance (?)
T13	CHEM 730 740	infliximab
#11	AnnotatorNotes T13	C0666743; infliximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	CHEM 742 752	adalimumab
#12	AnnotatorNotes T14	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T15	CHEM 755 773	certolizumab pegol
#13	AnnotatorNotes T15	C1872109; certolizumab pegol; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T16	PROC 817 828	diagnóstico
#14	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	DISO 832 848	colitis ulcerosa
#15	AnnotatorNotes T17	C0009324; Ulcerative Colitis; Disease or Syndrome
T18	DISO 850 852	CU
#16	AnnotatorNotes T18	C0009324; Ulcerative Colitis; Disease or Syndrome
T19	DISO 855 873	colitis colagenosa
#17	AnnotatorNotes T19	C0238067; Colitis, Collagenous; Disease or Syndrome
T20	DISO 876 897	colitis indeterminada
#18	AnnotatorNotes T20	C0341332; Indeterminate colitis; Disease or Syndrome
T21	PROC 938 969	resección quirúrgica intestinal
T22	PROC 1048 1055	ostomía
#19	AnnotatorNotes T22	C0029473; Ostomy; Therapeutic or Preventive Procedure
T23	ANAT 1058 1072	bolsa ileoanal
T24	DISO 1089 1121	estenosis intestinal sintomatica
T25	ANAT 1144 1152	perianal
#20	AnnotatorNotes T25	C0442158; Perianal; Body Location or Region
T26	DISO 1169 1197	síndrome del intestino corto
#21	AnnotatorNotes T26	C0036992; Short Bowel Syndrome; Disease or Syndrome
T27	DISO 1213 1230	infección crónica
#22	AnnotatorNotes T27	C0151317; Chronic Infection; Disease or Syndrome
T28	DISO 1250 1252	TB
T29	CHEM 140 147	ABT-494
#24	AnnotatorNotes T29	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T30	DISO 667 679	intolerancia
#25	AnnotatorNotes T30	C0277585; Intolerance to drug; Pathologic Function
T31	ANAT 959 969	intestinal
#26	AnnotatorNotes T31	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T32	ANAT 1099 1109	intestinal
#27	AnnotatorNotes T32	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T33	ANAT 1132 1141	abdominal
#28	AnnotatorNotes T33	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T34	ANAT 1182 1191	intestino
#29	AnnotatorNotes T34	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T35	Date 13 17	2014
T36	LIVB 202 211	pacientes
#30	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T38	LIVB 452 459	mujeres
#31	AnnotatorNotes T38	C0043210; Woman; Population Group
T39	Age 463 479	>=18 y <=75 años
T40	Duration 551 567	al menos 90 dias
T41	LIVB 609 617	paciente
#32	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 644 652	paciente
#33	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Duration 973 992	los 6 últimos meses
T45	LIVB 1034 1043	Pacientes
#34	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 1076 1084	Paciente
#35	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 1156 1164	Paciente
#36	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 1200 1208	Paciente
#37	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Duration 1223 1230	crónica
#38	AnnotatorNotes T49	C0205191; chronic; Temporal Concept
T37	LIVB 442 449	Varones
#39	AnnotatorNotes T37	C0025266; Male population group; Population Group
T50	DISO 345 355	no toleran
#40	AnnotatorNotes T50	C0277585; Intolerance to drug; Pathologic Function
A1	Status T11 History_of
A2	Status T30 History_of
A3	Status T12 History_of
A4	Status T13 History_of
A5	Status T14 History_of
A6	Status T15 History_of
A7	Status T21 History_of
A8	Status T22 History_of
#41	AnnotatorNotes T1	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product
#42	AnnotatorNotes T2	C0031019; Perianal abscess; Disease or Syndrome + C0243001; Abdominal Abscess; Disease or Syndrome
#23	AnnotatorNotes T28	C0041296; Tuberculosis; Disease or Syndrome
T44	Neg_cue 345 347	no
T51	Observation 348 355	toleran
A9	Assertion T51 Negated
T52	LIVB 900 909	Pacientes
#43	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 803 812	Pacientes
#44	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Observation 164 184	remisión sintomática
R1	Causes Arg1:T29 Arg2:T54
T55	Observation 164 172	remisión
#45	AnnotatorNotes T55	C0544452; Disease remission; Finding
#46	AnnotatorNotes T54	C0871467; Symptom Remission; Finding
R4	Experiences Arg1:T36 Arg2:T29
R5	Experiences Arg1:T36 Arg2:T54
R6	Experiences Arg1:T36 Arg2:T4
T56	Quantifier_or_Qualifier 236 242	activa
#47	AnnotatorNotes T56	C0679217; Active State; Idea or Concept
R7	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T56
T57	Quantifier_or_Qualifier 1253 1259	activa
#48	AnnotatorNotes T57	C0679217; Active State; Idea or Concept
R8	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T57
R9	Experiences Arg1:T48 Arg2:T27
R10	Experiences Arg1:T48 Arg2:T28
R11	Has_Duration_or_Interval Arg1:T27 Arg2:T49
R12	Location_of Arg1:T34 Arg2:T26
R13	Location_of Arg1:T32 Arg2:T24
R14	Location_of Arg1:T33 Arg2:T2
R15	Location_of Arg1:T25 Arg2:T2
R16	Experiences Arg1:T46 Arg2:T24
R17	Experiences Arg1:T46 Arg2:T2
R18	Experiences Arg1:T47 Arg2:T26
T58	Observation 1231 1241	recurrente
#49	AnnotatorNotes T58	C0679254; Disease recurrence; Finding
R19	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T58
T59	Quantifier_or_Qualifier 257 273	moderada a grave
#50	AnnotatorNotes T59	C1299393; Moderate to severe; Qualitative Concept
R20	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T59
T60	Observation 282 314	respondido de forma insuficiente
#51	AnnotatorNotes T60	C1320680; Poor response to treatment; Finding
R21	Experiences Arg1:T36 Arg2:T60
R22	Overlap Arg1:T60 Arg2:T5
R23	Experiences Arg1:T36 Arg2:T5
R24	Used_for Arg1:T6 Arg2:T5
R25	Negation Arg1:T44 Arg2:T51
R26	Experiences Arg1:T36 Arg2:T50
R27	Experiences Arg1:T36 Arg2:T51
R28	Overlap Arg1:T51 Arg2:T7
R29	Overlap Arg1:T50 Arg2:T7
R30	Experiences Arg1:T36 Arg2:T7
R31	Before Arg1:T4 Arg2:T54
R32	Experiences Arg1:T36 Arg2:T3
R33	Overlap Arg1:T5 Arg2:T51
R34	Overlap Arg1:T5 Arg2:T50
R35	Overlap Arg1:T60 Arg2:T7
R36	Has_Age Arg1:T37 Arg2:T39
R37	Has_Age Arg1:T38 Arg2:T39
T61	CONC 494 507	momento basal
#52	AnnotatorNotes T61	C1442488; Baseline; Quantitative Concept
R38	Overlap Arg1:T39 Arg2:T61
R39	Has_Duration_or_Interval Arg1:T10 Arg2:T40
T62	PROC 571 575	CDAI
#53	AnnotatorNotes T62	C5549856; Assessment using Simple Endoscopic Score for Crohn's Disease; Health Care Activity
T63	Result_or_Value 576 589	>=220 y <=450
R40	Has_Result_or_Value Arg1:T62 Arg2:T63
T64	Observation 595 604;626 638	respuesta insuficiente
#54	AnnotatorNotes T64	C1320680; Poor response to treatment; Finding
R41	Experiences Arg1:T41 Arg2:T64
R42	Experiences Arg1:T42 Arg2:T30
R43	Overlap Arg1:T64 Arg2:T11
R44	Causes Arg1:T11 Arg2:T30
R45	Used_for Arg1:T12 Arg2:T11
R46	Used_for Arg1:T13 Arg2:T11
R47	Used_for Arg1:T14 Arg2:T11
R48	Used_for Arg1:T15 Arg2:T11
R49	Experiences Arg1:T42 Arg2:T11
R50	Experiences Arg1:T42 Arg2:T64
R51	Experiences Arg1:T41 Arg2:T30
R52	Experiences Arg1:T41 Arg2:T11
R53	Experiences Arg1:T53 Arg2:T17
R54	Experiences Arg1:T53 Arg2:T18
R55	Experiences Arg1:T53 Arg2:T19
R56	Experiences Arg1:T53 Arg2:T20
R57	Experiences Arg1:T52 Arg2:T21
R58	Location_of Arg1:T31 Arg2:T21
R59	Overlap Arg1:T21 Arg2:T43
#55	AnnotatorNotes T21	C0741614; Bowel resection; Therapeutic or Preventive Procedure
R60	Experiences Arg1:T45 Arg2:T22
R2	Experiences Arg1:T36 Arg2:T55
R3	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T3
R61	Before Arg1:T4 Arg2:T55
A10	Experiencer T36 Patient
A11	Experiencer T37 Patient
A12	Experiencer T38 Patient
A13	Experiencer T41 Patient
A14	Experiencer T42 Patient
A15	Experiencer T53 Patient
A16	Experiencer T52 Patient
A17	Experiencer T45 Patient
A18	Experiencer T46 Patient
A19	Experiencer T47 Patient
A20	Experiencer T48 Patient
A21	Status T21 Future
